The Viral Antigens market was valued at US$101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027.
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A viral antigen is a poison or toxic substance administered by these virulent entities, which induces immune reaction in its host. For instance, a viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
Lucrative Regions in Viral Antigens Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increased Acceptance of Viral Antigens in Vaccine Development Fuels Market Growth
A viral antigen is a toxin or other substance released by a virus that is capable of inducing an immune response (to create an antibody) in the host organism. A viral protein is a viral genome-specified antigen that can be recognized by a specific immunological response. Vaccination aims to establish immunity in the host that, in the event of an infectious pathogen, will prevent illness. Therefore, in its simplest form, vaccine development for viral diseases involves the distribution of antigens that induce virus-specific neutralizing antibodies and avoid the induction of any off-target antibodies.The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology.
Products Insights
In terms of component, the Coronavirus antigens segment held the largest share of the viral antigens market in 2019, and is expected to continue its dominance and register a higher the highest CAGR in the market during the forecast period.Viral Antigens Market, by Component – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application Insights
Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.
A laboratory is a place where clinical specimen tests are conducted to collect information on the patient's health to help diagnose, treat, and prevent disease. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' services and their role in patients' clinical management. Laboratories differ in size and sophistication, providing a wide range of research facilities. More extensive services may be seen in Aacute care hospitals and medical centers might provide extensive services, where and 70% of clinical decisions are based on laboratory tests. Doctoral offices and clinics, and specialist nursing and long-term care facilities can have laboratories that offer more basic testing services. Accurate diagnosis of the virus requires laboratory examination of clinical specimens for the presence of viral antigens, viruses, or specific antibodies. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' service and their role in patients' clinical management.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Viral Antigens Market: Strategic Insights
Market Size Value in US$ 101.41 Million in 2019 Market Size Value by US$ 236.80 Million by 2027 Growth rate CAGR of 11.0% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Viral Antigens Market: Strategic Insights
| Market Size Value in | US$ 101.41 Million in 2019 |
| Market Size Value by | US$ 236.80 Million by 2027 |
| Growth rate | CAGR of 11.0% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Players operating in the viral antigens market adopt collaboration and partnership strategies to meet demands of end users through the introduction of technologically advanced offerings, and these strategies significantly support the growth of the market.
By Component
- Influenza Viral Antigens
- Coronavirus Antigens
- Zika Virus Antigens
- Ebola Virus Antigens
- Dengue Virus Antigens
- Herpes Simplex Virus (HSV) Viral Antigens
- Rotavirus Viral Antigens
- Hepatitis A-E Virus Antigens
- Measles Virus Antigens
- Mumps/Parotitis Virus Antigens
- Others
By Technique
- ELISA
- Immunoassay
- Hemagglutination
- Radioimmunoassay (RIA)
- Immunoperoxidase Staining
- Immunofluorescence
- Others
By End User
- Hospitals
- Clinics
- Laboratories
- Diagnostic Centers
- Blood Banks
- Research Institutes
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Russia
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- Microbix Biosystems
- BIO-RAD LABORATORIES INC.
- Creative Diagnostics
- Aalto Bio Reagents Ltd.
- Advanced Biotechnologies Inc.
- Prospec-Tany Technogene Ltd.
- ACROBiosystems.
- MERIDIAN BIOSCIENCE, INC.
- Rekom Biotech S.L
- LGC Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Component Antigens ; Technique ; and End User ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.
The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Viral Antigens Market – By Component
1.3.2 Global Viral Antigens Market – By Technique
1.3.3 Global Viral Antigens Market – By End User
1.3.4 Global Viral Antigens Market – By Geography
2. Viral Antigens Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Viral Antigens Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Viral Antigens Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increased Acceptance of Viral Antigens in Vaccine Development
5.1.2 Advancements in Image Analysis Software and Informatics Platforms for Viral Antigen Detection
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Growing Trend of Plant-Made Vaccine Antigens and Biopharmaceuticals
5.5 Impact Analysis
6. Viral Antigens Market – Global Analysis
6.1 Global Viral Antigens Market Revenue Forecast And Analysis
6.2 Global Viral Antigens Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Viral Antigens Market– By Component
7.1 Overview
7.2 Viral Antigens Market Share, by Component, 2019 and 2027 (%)
7.3 Influenza Viral Antigens
7.3.1 Overview
7.3.2 Influenza Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.4 Coronavirus Antigens
7.4.1 Overview
7.4.2 Coronavirus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.5 Zika Virus Antigens
7.5.1 Overview
7.5.2 Zika Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.6 Ebola Virus Antigens
7.6.1 Overview
7.6.2 Ebola Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.7 Dengue Virus Antigens
7.7.1 Overview
7.7.2 Dengue Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.8 Herpes Simplex Virus (HSV) Viral Antigens
7.8.1 Overview
7.8.2 Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.9 Rotavirus Viral Antigens
7.9.1 Overview
7.9.2 Rotavirus Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.10 Hepatitis A-E Virus Antigens
7.10.1 Overview
7.10.2 Hepatitis A-E Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.11 Measles Virus Antigens
7.11.1 Overview
7.11.2 Measles Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.12 Mumps/Parotitis Virus Antigens
7.12.1 Overview
7.12.2 Mumps/Parotitis Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
7.13 Others
7.13.1 Overview
7.13.2 Others: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
8. Viral Antigens Market Analysis – By Technique
8.1 Overview
8.2 Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
8.3 ELISA
8.3.1 Overview
8.3.2 ELISA: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Immunoassay
8.4.1 Overview
8.4.2 Immunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Hemagglutination
8.5.1 Overview
8.5.2 Hemagglutination: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Radioimmunoassay (RIA)
8.6.1 Overview
8.6.2 Radioimmunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Immunoperoxidase Staining
8.7.1 Overview
8.7.2 Immunoperoxidase Staining: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Immunofluorescence
8.8.1 Overview
8.8.2 Immunofluorescence: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9. Viral Antigens Market Analysis – By End User
9.1 Overview
9.2 Viral Antigens Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Laboratories
9.5.1 Overview
9.5.2 Laboratories: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Diagnostic Centres
9.6.1 Overview
9.6.2 Diagnostic Centres: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Blood Banks
9.7.1 Overview
9.7.2 Blood Banks: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Research Institutes
9.8.1 Overview
9.8.2 Research Institutes: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
10. Viral Antigens Market – Geographic Analysis
10.1 North America: Viral Antigens Market
10.1.1 Overview
10.1.2 North America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.1.4 North America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.1.5 North America: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.1.6 North America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.1.7 US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.1.7.3 US: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.1.7.4 US: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.1.8 Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.1.8.3 Canada: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.1.8.4 Canada: viral antigens market, by End User, 2018–2027 (USD million)
10.1.9 Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.1.9.3 Mexico: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.1.9.4 Mexico: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2 Europe: Viral Antigens Market
10.2.1 Overview
10.2.2 Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.4 Europe: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.5 Europe: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.2.6 Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.6.1 Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.6.2 Germany: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.6.3 Germany: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.6.4 Germany: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2.7 UK: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 UK Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 UK: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.7.3 UK: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.7.4 UK: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2.8 France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 France: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.8.3 France: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.8.4 France: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2.8.5 Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.6 Spain: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.8.7 Spain: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.8.8 Spain: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2.9 Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 Italy: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.9.3 Italy: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.9.4 Italy: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.2.10 Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Rest of Europe: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.2.10.3 Rest of Europe: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.2.10.4 Rest of Europe: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3 Asia Pacific: Viral Antigens Market
10.3.1 Overview
10.3.2 Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.3.7 China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.7.3 China: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.7.4 China: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3.8 Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.8.3 Japan: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.8.4 Japan: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3.9 India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.9.3 India: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.9.4 India: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3.10 South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.10.3 South Korea: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.10.4 South Korea: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3.10.5 Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.6 Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.7 Australia: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.10.8 Australia: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.10.9 Australia: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.3.11 Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Rest of Asia Pacific: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.3.11.3 Rest of Asia Pacific: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.3.11.4 Rest of Asia Pacific: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.4 Middle East & Africa: Viral Antigens Market
10.4.1 Overview
10.4.2 Middle East & Africa: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.4.8 UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.4.8.3 UAE: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.4.8.4 UAE: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.4.9 South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.4.9.3 South Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.4.9.4 South Africa: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.4.10 Rest of Middle East and Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Viral Antigens Market, by End User, 2018–2027 (USD million)
10.5 South and Central America: Viral Antigens Market
10.5.1 Overview
10.5.2 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.5.3 South and Central America: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.5.4 South and Central America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.5.5 South and Central America: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.5.6 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.8 Brazil: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.5.9 Brazil: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.5.10 Brazil: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.5.11 Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.11.1 Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.12 Argentina: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.5.13 Argentina: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.5.14 Argentina: Viral Antigens Market, by End User, 2018–2027 (USD Million)
10.5.15 Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.15.1 Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
10.5.16 Rest of Central and South America: Viral Antigens Market, by Component, 2018–2027 (USD Million)
10.5.17 Rest of Central and South America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)
10.5.18 Rest of Central and South America: Viral Antigens Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Viral Antigens Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe (EU): Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Viral Antigens Market– Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Microbix Biosystems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BIO-RAD LABORATORIES INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Creative Diagnostics
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aalto Bio Reagents Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Advanced Biotechnologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Prospec-Tany Technogene Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ACROBiosystems.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Rekom Biotech S.L
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 LGC Limited.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Viral Antigens Market Share, by Component, 2019 and 2027 (%)
Table 2. North America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. US Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 6. US Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 7. US Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 16. Europe Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)
Table 18. Germany Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 19. Germany Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 20. Germany Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. UK Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 22. UK Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 23. UK Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 24. France Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 25. France Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 26. France Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Italy Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 32. Italy Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 33. Italy Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Rest of Europe Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Europe Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Europe Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. Asia Pacific Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 38. Asia Pacific Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 39. Asia Pacific Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 40. China Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 41. China Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 42. China Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 43. Japan Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 44. Japan Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 45. Japan Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 46. India Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 47. India Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 48. India Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 49. South Korea Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 50. South Korea Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 51. South Korea Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 52. Australia Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 53. Australia Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 54. Australia Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 55. Rest of Asia Pacific Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 56. Rest of Asia Pacific Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 57. Rest of Asia Pacific Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 58. Middle East & Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 59. Middle East & Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 60. Middle East & Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 61. Saudi Arabia Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 62. Saudi Arabia Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 63. Saudi Arabia Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 64. UAE Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 65. UAE Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 66. UAE Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 67. South Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 68. South Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 69. South Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Middle East and Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 71. Rest of Middle East and Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 72. Rest of Middle East and Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 73. South and Central America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 74. South and Central America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 75. South and Central America Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. Brazil Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 77. Brazil Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 78. Brazil Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 79. Argentina Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 80. Argentina Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 81. Argentina Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 82. Rest of Central and South America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 83. Rest of Central and South America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)
Table 84. Rest of Central and South America Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 85. Organic Developments Done By Companies
Table 86. Inorganic Developments Done By Companies
Table 87. Glossary of Terms, Viral antigens Market
LIST OF FIGURES
Figure 1. Viral Antigens Market Segmentation
Figure 2. Viral Antigens Market, By Region
Figure 3. Global Viral Antigens Market Overview
Figure 4. The Coronavirus Antigens Segment Held Largest Share of Component Segment In Viral Antigens Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Viral Antigens Market, By Geography (USD Million)
Figure 7. Global Viral Antigens Market- Leading Country Markets (USD Million)
Figure 8. Global Viral Antigens Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Global Viral Antigens Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Viral Antigens Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Viral Antigens Market
Figure 18. Viral Antigens Market Share, by Component, 2019 and 2027 (%)
Figure 19. Influenza Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 20. Coronavirus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 21. Zika Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 22. Ebola Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 23. Dengue Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 24. Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 25. Rotavirus Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 26. Hepatitis A-E Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 27. Measles Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 28. Mumps/Parotitis Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 29. Others: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)
Figure 30. Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
Figure 31. ELISA: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Immunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Hemagglutination: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Radioimmunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Immunoperoxidase Staining: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Immunofluorescence: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 37. Others: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Viral Antigens Market Share, by End User, 2019 and 2027 (%)
Figure 39. Hospitals: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 40. Clinics: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 41. Laboratories: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 42. Diagnostic Centres: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 43. Blood Banks: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 44. Research Institutes: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)
Figure 45. North America: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. North America Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
Figure 47. North America: Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 48. US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Europe: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)
Figure 52. Europe Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
Figure 53. Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 54. Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. UK: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Asia Pacific: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)
Figure 61. Asia Pacific Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
Figure 62. China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. Middle East & Africa: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)
Figure 69. Middle East & Africa Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
Figure 70. Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 71. Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 72. UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 73. South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 74. Rest of Middle East and Africa: Pulse Oximeters Market – Revenue and Forecast to 2027 (USD Million)
Figure 75. South and Central America: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)
Figure 76. South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 77. South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 78. Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 79. Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 80. Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)
Figure 81. Impact of COVID-19 Pandemic in North American Country Markets
Figure 82. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 83. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 84. Impact of COVID-19 Pandemic in Middle East & Africa Market
Figure 85. Impact of COVID-19 Pandemic in South and Central America Market
Figure 86. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Viral Antigens Market
- Microbix Biosystems
- BIO-RAD LABORATORIES INC.
- Creative Diagnostics
- Aalto Bio Reagents Ltd.
- Advanced Biotechnologies Inc.
- Prospec-Tany Technogene Ltd.
- ACROBiosystems.
- MERIDIAN BIOSCIENCE, INC.
- Rekom Biotech S.L
- LGC Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Viral Antigens Market
Dec 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Dec 2020